Theracryf Plc (TCF.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,131 | 2,033 | 3,626 | 3,859 | 5,120 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2,006 |
| Other current assets | 531 | 589 | 463 | 692 | 139 |
| TOTAL | $4,773 | $2,660 | $4,135 | $4,603 | $7,320 |
| Non-Current Assets | |||||
| PPE Net | 2 | 6 | 12 | 11 | 6 |
| Intangibles | 82 | 98 | 113 | 128 | 74 |
| TOTAL | $84 | $104 | $125 | $139 | $80 |
| Total Assets | $4,857 | $2,764 | $4,260 | $4,742 | $7,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 516 | 532 | 102 | 164 | 86 |
| TOTAL | $653 | $688 | $389 | $514 | $313 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $653 | $688 | $389 | $514 | $313 |
| Shareholders' Equity | |||||
| Common Shares | 331 | 247 | 233 | 183 | 183 |
| Retained earnings | -17,915 | -15,200 | -12,576 | -9,993 | -6,925 |
| Other shareholders' equity | 3,957 | 3,789 | 3,654 | 3,543 | 3,334 |
| TOTAL | $4,204 | $2,076 | $3,871 | $4,228 | $7,087 |
| Total Liabilities And Equity | $4,857 | $2,764 | $4,260 | $4,742 | $7,400 |